Sara Jacobs is having a busy week on the Hill. On one hand, she's co-sponsoring a bill to protect reproductive health records from federal surveillance. On the other, her stock disclosure filings show she spent two consecutive days in early May selling up to $1 million worth of Qualcomm shares each day. One story is about privacy. The other one involves Qualcomm. Both involve Sara Jacobs. The public record is allowed to notice.
The Legislation
Jacobs, a California Democrat, joined Reps. Jennifer McClellan and Sen. Mazie Hirono this week to introduce legislation aimed at keeping pregnancy termination and pregnancy loss data out of the hands of people who might use it against women. The vehicle is HIPAA. The argument is that existing federal health privacy rules don't do enough to wall off that specific category of reproductive health information, and the bill would tighten those protections explicitly.
It's a messaging bill with real stakes, introduced at a political moment when surveillance of reproductive health data is not an abstract concern. Bluesky has already picked it up, with small clusters of posts circulating the bill number and noting Jacobs's involvement. The social footprint is modest right now, four Bluesky posts in the data window, but the bill has the kind of searchable issue profile that tends to compound.
Jacobs sits on the House Committee on Armed Services and the House Committee on Foreign Affairs. Neither of those committees has jurisdiction over health privacy legislation. This is a floor-level policy move, not an oversight assignment. Worth naming clearly before we get to the part about Qualcomm.
The Trades
On May 6 and May 7, Jacobs filed two separate sale disclosures, each for Qualcomm ($QCOM), each in the $500,000 to $1,000,000 range. Two consecutive days. Same ticker. Combined disclosure window: up to $2 million out the door.
Per her full disclosure record on Blind Trust, these are the only two trades she's filed in the last 90 days. The entire recent trading picture is: Qualcomm, sell, sell, done.
The timing note writes itself. May 6 and May 7 are not congressional recess. The House was in session. Members vote on the floor on bills entirely outside their committees all the time, which is worth keeping in mind. But the calendar is the calendar.
What the Alpha Record Actually Says
Blind Trust scores each trade by 30-day excess return against the S&P 500. On a two-trade sample, Jacobs is 1 for 2 with a mean alpha of 0.3 percent. The May 6 sale came in at plus-4.2 percent alpha over the following 30 days. The May 7 sale, filed one day later on the same ticker, came in at minus-3.5 percent.
Read that again: two trades on consecutive days in identical positions, and they scored on opposite sides. One outperformed the market by 4.2 points. The next one underperformed by 3.5. The combined mean lands at 0.3 percent, which is roughly market-neutral.
If you came here looking for evidence of a secret edge, the math does not cooperate. What the record shows is two large sales, modest aggregate performance, and a sample size of two, which is not enough to tell you anything about skill. It is, however, enough to tell you that someone sold up to $2 million in Qualcomm across two consecutive days in May, and that's a fact.
The Committee Overlap Problem
Here's where it gets structurally interesting, even if it doesn't resolve cleanly. Blind Trust's system flags both QCOM trades as carrying a committee overlap under the "Technology" tag. Jacobs's listed committee assignments are Armed Services and Foreign Affairs. Neither of those is a technology committee in the Financial Services or Science/Commerce sense.
The overlap tag exists because Qualcomm's business intersects with defense and foreign affairs in ways that are not purely theoretical. Qualcomm makes the chips that go into smartphones, yes, but also into defense-grade communication systems, satellite infrastructure, and the kind of wireless technology that's squarely on the agenda of Armed Services and Foreign Affairs committees when they're thinking about supply chain security, export controls, and what the U.S. Sends allies.
That doesn't establish a conflict. It does mean Jacobs's committee work is not categorically separate from the industry that Qualcomm operates in. The gap between "her committee has no jurisdiction over this" and "her committee never touches technology companies" is real. Members are required to disclose. They're not required to divest, recuse, abstain, or explain. That's the rule.
The Floor Votes: Banking Bills, No Chipmakers
Jacobs's recent floor votes are worth a quick scan for context, even though they don't create the overlap angle. On May 20, she voted Yea on four separate pieces of banking and financial-access legislation that passed the House: the American Access to Banking Act (H.R. 4544), the Community Bank Deposit Access Act of 2025 (H.R. 5317), the Keeping Deposits Local Act (H.R. 3234), and the 25th Anniversary of 9/11 Commemorative Coin Act (H.R. 1993). All four passed.
On June 25, she voted Yea on the Financial Exploitation Prevention Act of 2025 (H.R. 2478), which also passed. On June 11, she voted Nay on the FISA reauthorization bill, which failed.
None of these votes are on her committees. None are directly in Qualcomm's sector. The banking cluster is a floor vote pattern that a lot of members shared that day, and Jacobs's Yea votes there don't tell you anything specific about her. The FISA Nay is mildly interesting given that she sits on Intelligence and Special Operations under Armed Services, but the bill failed, so the outcome was not hers to control.
The point: her floor voting record in the window surrounding the Qualcomm sales does not surface a clean vote-trade overlap. Blind Trust found no flagged pairings. The trades stand on their own.
The Qualcomm Picture
Qualcomm had a complicated spring. The company has been navigating ongoing licensing disputes, shifting smartphone demand cycles, and the broader uncertainty around semiconductor export controls and U.S.-China trade friction. For a company whose revenue depends substantially on chips inside devices sold into Chinese markets, the macro backdrop in May was not serene.
None of that tells you why Jacobs sold. Portfolio rebalancing, estate planning, a financial advisor's recommendation, a change in household circumstances: all of those are explanations that the disclosure filing cannot rule out, because the filing doesn't ask. The filing asks what was traded and when. It stops there.
What the filing says: up to $2 million in Qualcomm exited her portfolio over 48 hours in early May. The receipts are public. Make of them what you make of them.
The Bigger Pattern
Jacobs is not a high-volume trader. Two trades in 90 days is a quiet quarter by congressional standards. It's the concentration. When she did trade, she traded one thing, in size, twice in a row.
Combined with her current public profile, which right now is about privacy and the protection of sensitive health data, the juxtaposition is at minimum worth a note. A lawmaker introducing a bill premised on the idea that sensitive personal data deserves protection from misuse has also filed disclosures showing up to $2 million in chip-company sales. The two things don't contradict each other. They also don't fully sit still next to each other.
She sits on Armed Services. Qualcomm's chips are in defense communications systems. The connection is not obvious and the data doesn't prove it. But the data doesn't make it disappear either.
Jacobs's full disclosure record is available at Blind Trust. The bill she co-introduced with McClellan and Hirono is indexed at Quiver Quantitative. The timeline is yours to read.